SCHEMBL286143

SCHEMBL286143

CCCCc1noc(C)c1COc1cc(C(=O)OCC(N)=O)n(C)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.35
LMNA P02545 3/20 0.35
GABRA5 P31644 1/20 0.34
L3MBTL1 Q9Y468 4/20 0.34
TDP1 Q9NUW8 2/20 0.34
MEN1 O00255 2/20 0.33
GAA P10253 2/20 0.33
KMT2A Q03164 2/20 0.33
GABRA1 P14867 2/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MAPT P10636 2/20 0.33
TSHR P16473 2/20 0.33
MAPK1 P28482 1/20 0.33
POLB P06746 1/20 0.32
TAS2R8 Q9NYW2 1/20 0.32
NR1H4 Q96RI1 1/20 0.32
CYP1A2 P05177 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL286377 0.88 GABRA5 (0.39) ALDH1A1GABRA5L3MBTL1MEN1KMT2A
SCHEMBL286709 0.86 KMT2A (0.40) ALDH1A1GABRA5L3MBTL1MEN1GAA
SCHEMBL286369 0.85 NR1H4 (0.40) GABRA5L3MBTL1GAAGABRA1NR1H4
SCHEMBL285773 0.81 POLB (0.40) GABRA5L3MBTL1GABRA1POLBTAS2R8
SCHEMBL285772 0.81 GABRA5 (0.42) GABRA5GABRA1
SCHEMBL286463 0.81 ALDH1A1 (0.34) ALDH1A1LMNAGABRA5L3MBTL1TDP1
SCHEMBL286142 0.80 GABRA1 (0.43) GABRA5GABRA1TAS2R8
SCHEMBL286645 0.80 GABRA5 (0.55) GABRA5
SCHEMBL291879 0.79 GABRA5 (0.54) GABRA5GABRA1
SCHEMBL286209 0.78 GABRA5 (0.44) GABRA5GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8163728-B2 Pyrazoles HOFFMANN-LA ROCHE INC. (US) 2012-04-24 US disclosed
EP-2427455-A1 ISOXAZOLE-PYRAZOLE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2012-03-14 EP disclosed